Koninklijke Philips N.V.
General ticker "RYLPF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $24.1B (TTM average)
Koninklijke Philips N.V. follows the US Stock Market performance with the rate: 42.5%.
Estimated limits based on current volatility of 0.9%: low 26.48$, high 26.99$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-05-13, amount 0.96$ (Y3.60%)
- Total employees count: 234000 as of 1998
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [20.24$, 32.49$]
- 2025-12-31 to 2026-12-31 estimated range: [20.74$, 33.18$]
Financial Metrics affecting the RYLPF estimates:
- Negative: with PPE of -32.3 at the end of fiscal year the price was very high
- Positive: -3.60 < Operating profit margin, % of 2.94
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of -2.82
- Positive: 6.82 < Operating cash flow per share per price, % of 6.95
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 1.50 <= 3.41
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: 18.93 < Shareholder equity ratio, % of 41.43 <= 41.86
- Positive: Inventory ratio change, % of -0.79 <= -0.75
Short-term RYLPF quotes
Long-term RYLPF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | €18,169.00MM | €18,021.00MM |
| Operating Expenses | €18,284.00MM | €17,492.00MM |
| Operating Income | €-115.00MM | €529.00MM |
| Non-Operating Income | €-412.00MM | €-406.00MM |
| Interest Expense | €306.00MM | €337.00MM |
| R&D Expense | €1,890.00MM | €1,747.00MM |
| Income(Loss) | €-527.00MM | €123.00MM |
| Taxes | €-73.00MM | €963.00MM |
| Profit(Loss)* | €-466.00MM | €-702.00MM |
| Stockholders Equity | €12,028.00MM | €12,006.00MM |
| Inventory | €3,491.00MM | €3,198.00MM |
| Assets | €29,406.00MM | €28,976.00MM |
| Operating Cash Flow | €2,259.00MM | €1,556.00MM |
| Capital expenditure | €644.00MM | €676.00MM |
| Investing Cash Flow | €-636.00MM | €-573.00MM |
| Financing Cash Flow | €-848.00MM | €-496.00MM |
| Earnings Per Share** | €-0.50 | €-0.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.